UnitedHealth Group (UNH) Stock Forecast & Price Target

$524.78 +15.02 (+2.95%)

Closing price 03:59 PM Eastern

Extended Trading

$523.54 -1.24 (-0.24%)

As of 07:08 PM Eastern

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 22 Analyst Ratings

Sell
0

Hold
1

Buy
21

Based on 22 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 22 analysts, 1 has given a hold rating, 19 have given a buy rating, and 2 have given a strong buy rating for UNH.

Consensus Price Target

$627.74
19.62% Upside

According to the 22 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $627.74. The highest price target for UNH is $700.00, while the lowest price target for UNH is $559.00. The average price target represents a forecasted upside of 19.62% from the current price of $524.78.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

UNH Analyst Ratings Over Time

Type	Current Forecast 1/22/24 to 1/21/25	1 Month Ago 12/23/23 to 12/22/24	3 Months Ago 10/24/23 to 10/23/24	1 Year Ago 1/22/23 to 1/22/24
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	19 Buy rating(s)	17 Buy rating(s)	17 Buy rating(s)	13 Buy rating(s)
Hold	1 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$627.74	$626.84	$615.53	$575.79
Forecasted Upside	19.62% Upside	25.34% Upside	9.04% Upside	12.18% Upside
Consensus Rating	Buy	Moderate Buy	Moderate Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	3.05	2.82	2.52
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	19.62% Upside	24,936.03% Upside	11.17% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/17/2025	Barclays 3 of 5 stars	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$655.00 ➝ $642.00	+24.45%
1/17/2025	KeyCorp 3 of 5 stars	M. Gillmor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$650.00 ➝ $650.00	+25.39%
1/17/2025	Cantor Fitzgerald 4 of 5 stars	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$700.00 ➝ $700.00	+36.71%
1/10/2025	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
1/10/2025	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$595.00	+11.26%
1/6/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$625.00 ➝ $610.00	+18.91%
1/2/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$605.00 ➝ $600.00	+18.61%
12/6/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$610.00 ➝ $640.00	+14.74%
12/5/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$605.00 ➝ $675.00	+10.54%
12/3/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$595.00 ➝ $625.00	+2.72%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
10/18/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$601.00 ➝ $609.00	+7.84%
10/16/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$680.00 ➝ $650.00	+13.16%
10/16/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$615.00 ➝ $595.00	+7.31%
10/16/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$675.00 ➝ $650.00	+17.23%
10/16/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$615.00 ➝ $610.00	+10.02%
7/17/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$570.00 ➝ $600.00	+4.95%
7/17/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$525.00 ➝ $630.00	+11.23%
7/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$597.00 ➝ $640.00	+16.60%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$546.00 ➝ $559.00	+15.75%
3/13/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/18/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$595.00 ➝ $603.00	+24.55%
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$600.00 ➝ $549.00	+18.56%
6/14/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$625.00 ➝ $560.00	+13.98%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$590.00 ➝ $600.00	+17.24%
4/14/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Strong-Buy	$630.00	+24.75%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:09 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 12, 2025. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

Strong Earnings Performance: UnitedHealth Group recently reported earnings per share (EPS) of $7.15, exceeding the consensus estimate of $7.00. This indicates robust financial health and effective management, which can lead to increased investor confidence.
Revenue Growth: The company achieved a revenue of $100.82 billion for the latest quarter, surpassing expectations and reflecting a year-over-year growth of 9.2%. This consistent revenue increase suggests a strong market position and potential for future profitability.
Positive Analyst Ratings: The stock has received a consensus rating of "Moderate Buy" from analysts, with a significant number of buy ratings. This indicates a favorable outlook from market experts, which can attract more investors.
Current Stock Price: UnitedHealth Group's stock is currently trading at $524.14, which may present a buying opportunity for investors looking for growth potential, especially given its 52-week high of $630.73.
Dividend Payments: The company has a quarterly dividend of $2.10, translating to an annualized dividend of $8.40 and a yield of 1.60%. This provides a steady income stream for investors, enhancing the attractiveness of the stock.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

Recent Target Price Reductions: Analysts have recently lowered their target prices for UnitedHealth Group, with Bank of America reducing it from $675.00 to $650.00. Such downgrades can signal potential concerns about the company's future performance.
High Price-to-Earnings Ratio: The company has a price-to-earnings (P/E) ratio of 34.15, which is relatively high compared to industry averages. This could indicate that the stock is overvalued, making it a riskier investment.
Debt Levels: UnitedHealth Group has a debt-to-equity ratio of 0.74, which, while manageable, suggests that the company is utilizing debt to finance its operations. High levels of debt can pose risks, especially in economic downturns.
Market Volatility: The stock has a beta of 0.62, indicating lower volatility compared to the market. While this can be seen as a positive, it may also suggest limited growth potential in a bullish market.
Mixed Analyst Sentiment: While many analysts have a positive outlook, there are still a few hold ratings, indicating some uncertainty about the stock's future performance. This mixed sentiment can create hesitation among potential investors.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $627.74, with a high forecast of $700.00 and a low forecast of $559.00.
: 22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There is currently 1 hold rating, 19 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UNH shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 19.62% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 2 upgrades by analysts.
: UnitedHealth Group has been rated by research analysts at Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Hsbc Global Res, HSBC, KeyCorp, Oppenheimer, Piper Sandler, Stephens, and Truist Financial in the past 90 days.
: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:UNH) was last updated on 1/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target